nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—SHBG—obesity	0.235	0.318	CbGaD
Fluoxymesterone—AR—obesity	0.206	0.279	CbGaD
Fluoxymesterone—ESR1—obesity	0.158	0.215	CbGaD
Fluoxymesterone—NR3C1—obesity	0.139	0.189	CbGaD
Fluoxymesterone—ESR1—ovarian follicle—obesity	0.00871	0.204	CbGeAlD
Fluoxymesterone—PRLR—liver—obesity	0.00358	0.0838	CbGeAlD
Fluoxymesterone—Polycythaemia—Topiramate—obesity	0.0033	0.0532	CcSEcCtD
Fluoxymesterone—SHBG—hindbrain—obesity	0.00267	0.0626	CbGeAlD
Fluoxymesterone—Menstruation irregular—Orlistat—obesity	0.00242	0.0391	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Diethylpropion—obesity	0.00228	0.0368	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Cimetidine—obesity	0.00217	0.035	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Bupropion—obesity	0.00204	0.033	CcSEcCtD
Fluoxymesterone—Clotting—Topiramate—obesity	0.00201	0.0325	CcSEcCtD
Fluoxymesterone—Hirsutism—Bupropion—obesity	0.00194	0.0314	CcSEcCtD
Fluoxymesterone—ESR1—hindbrain—obesity	0.00188	0.0441	CbGeAlD
Fluoxymesterone—Amenorrhoea—Orlistat—obesity	0.00152	0.0246	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Sibutramine—obesity	0.00147	0.0238	CcSEcCtD
Fluoxymesterone—NR3C1—hindbrain—obesity	0.00139	0.0325	CbGeAlD
Fluoxymesterone—Amenorrhoea—Bupropion—obesity	0.00129	0.0208	CcSEcCtD
Fluoxymesterone—SHBG—cardiovascular system—obesity	0.00125	0.0293	CbGeAlD
Fluoxymesterone—ESR1—respiratory system—obesity	0.00115	0.0269	CbGeAlD
Fluoxymesterone—Anxiety—Phenylpropanolamine—obesity	0.00114	0.0183	CcSEcCtD
Fluoxymesterone—Alopecia—Diethylpropion—obesity	0.00113	0.0183	CcSEcCtD
Fluoxymesterone—SHBG—pituitary gland—obesity	0.00111	0.0259	CbGeAlD
Fluoxymesterone—SHBG—adipose tissue—obesity	0.0011	0.0258	CbGeAlD
Fluoxymesterone—Alopecia—Cimetidine—obesity	0.00108	0.0174	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Methamphetamine—obesity	0.00107	0.0173	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Topiramate—obesity	0.00106	0.0171	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Benzphetamine—obesity	0.00103	0.0167	CcSEcCtD
Fluoxymesterone—Libido decreased—Sibutramine—obesity	0.00101	0.0164	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Bupropion—obesity	0.00101	0.0163	CcSEcCtD
Fluoxymesterone—SHBG—adrenal gland—obesity	0.000989	0.0231	CbGeAlD
Fluoxymesterone—AR—adrenal cortex—obesity	0.000983	0.023	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Sibutramine—obesity	0.000972	0.0157	CcSEcCtD
Fluoxymesterone—Anxiety—Diethylpropion—obesity	0.000945	0.0153	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Sibutramine—obesity	0.000933	0.0151	CcSEcCtD
Fluoxymesterone—Coagulopathy—Topiramate—obesity	0.000924	0.0149	CcSEcCtD
Fluoxymesterone—Headache—Methamphetamine—obesity	0.000911	0.0147	CcSEcCtD
Fluoxymesterone—Anxiety—Cimetidine—obesity	0.000899	0.0145	CcSEcCtD
Fluoxymesterone—NR3C1—islet of Langerhans—obesity	0.000899	0.021	CbGeAlD
Fluoxymesterone—AR—cardiovascular system—obesity	0.000897	0.021	CbGeAlD
Fluoxymesterone—Libido decreased—Bupropion—obesity	0.000884	0.0143	CcSEcCtD
Fluoxymesterone—ESR1—cardiovascular system—obesity	0.000881	0.0206	CbGeAlD
Fluoxymesterone—Headache—Benzphetamine—obesity	0.000879	0.0142	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Cimetidine—obesity	0.000865	0.014	CcSEcCtD
Fluoxymesterone—SHBG—endocrine gland—obesity	0.000858	0.0201	CbGeAlD
Fluoxymesterone—NR3C1—respiratory system—obesity	0.000849	0.0199	CbGeAlD
Fluoxymesterone—Nausea—Benzphetamine—obesity	0.000833	0.0135	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Topiramate—obesity	0.000819	0.0132	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Bupropion—obesity	0.000813	0.0131	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Phenylpropanolamine—obesity	0.000805	0.013	CcSEcCtD
Fluoxymesterone—Headache—Phendimetrazine—obesity	0.000801	0.0129	CcSEcCtD
Fluoxymesterone—AR—pituitary gland—obesity	0.000794	0.0186	CbGeAlD
Fluoxymesterone—AR—adipose tissue—obesity	0.000791	0.0185	CbGeAlD
Fluoxymesterone—ESR1—pituitary gland—obesity	0.00078	0.0183	CbGeAlD
Fluoxymesterone—ESR1—adipose tissue—obesity	0.000777	0.0182	CbGeAlD
Fluoxymesterone—SHBG—liver—obesity	0.000773	0.0181	CbGeAlD
Fluoxymesterone—Nausea—Phendimetrazine—obesity	0.000759	0.0123	CcSEcCtD
Fluoxymesterone—AR—digestive system—obesity	0.000745	0.0174	CbGeAlD
Fluoxymesterone—ESR1—digestive system—obesity	0.000731	0.0171	CbGeAlD
Fluoxymesterone—NR3C1—adrenal cortex—obesity	0.000712	0.0167	CbGeAlD
Fluoxymesterone—AR—adrenal gland—obesity	0.00071	0.0166	CbGeAlD
Fluoxymesterone—ESR1—adrenal gland—obesity	0.000697	0.0163	CbGeAlD
Fluoxymesterone—Haemoglobin—Orlistat—obesity	0.000676	0.0109	CcSEcCtD
Fluoxymesterone—Haemorrhage—Orlistat—obesity	0.000672	0.0109	CcSEcCtD
Fluoxymesterone—Headache—Phentermine—obesity	0.000655	0.0106	CcSEcCtD
Fluoxymesterone—Haemoglobin—Sibutramine—obesity	0.000654	0.0106	CcSEcCtD
Fluoxymesterone—Haemorrhage—Sibutramine—obesity	0.000651	0.0105	CcSEcCtD
Fluoxymesterone—NR3C1—cardiovascular system—obesity	0.00065	0.0152	CbGeAlD
Fluoxymesterone—Nausea—Phenylpropanolamine—obesity	0.000649	0.0105	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Cimetidine—obesity	0.000637	0.0103	CcSEcCtD
Fluoxymesterone—Nausea—Phentermine—obesity	0.000621	0.01	CcSEcCtD
Fluoxymesterone—AR—endocrine gland—obesity	0.000615	0.0144	CbGeAlD
Fluoxymesterone—ESR1—endocrine gland—obesity	0.000604	0.0141	CbGeAlD
Fluoxymesterone—Alopecia—Orlistat—obesity	0.000594	0.0096	CcSEcCtD
Fluoxymesterone—NR3C1—pituitary gland—obesity	0.000575	0.0135	CbGeAlD
Fluoxymesterone—Alopecia—Sibutramine—obesity	0.000575	0.00929	CcSEcCtD
Fluoxymesterone—NR3C1—adipose tissue—obesity	0.000573	0.0134	CbGeAlD
Fluoxymesterone—Haemoglobin—Bupropion—obesity	0.00057	0.00921	CcSEcCtD
Fluoxymesterone—Headache—Diethylpropion—obesity	0.00057	0.0092	CcSEcCtD
Fluoxymesterone—Haemorrhage—Bupropion—obesity	0.000567	0.00916	CcSEcCtD
Fluoxymesterone—Libido decreased—Topiramate—obesity	0.000563	0.0091	CcSEcCtD
Fluoxymesterone—AR—liver—obesity	0.000555	0.013	CbGeAlD
Fluoxymesterone—ESR1—liver—obesity	0.000545	0.0127	CbGeAlD
Fluoxymesterone—Headache—Cimetidine—obesity	0.000542	0.00876	CcSEcCtD
Fluoxymesterone—Nausea—Diethylpropion—obesity	0.00054	0.00872	CcSEcCtD
Fluoxymesterone—NR3C1—digestive system—obesity	0.000539	0.0126	CbGeAlD
Fluoxymesterone—Disturbance in sexual arousal—Topiramate—obesity	0.000518	0.00837	CcSEcCtD
Fluoxymesterone—NR3C1—adrenal gland—obesity	0.000514	0.012	CbGeAlD
Fluoxymesterone—Nausea—Cimetidine—obesity	0.000514	0.0083	CcSEcCtD
Fluoxymesterone—Alopecia—Bupropion—obesity	0.000501	0.0081	CcSEcCtD
Fluoxymesterone—Anxiety—Orlistat—obesity	0.000496	0.00802	CcSEcCtD
Fluoxymesterone—Anxiety—Sibutramine—obesity	0.00048	0.00776	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Orlistat—obesity	0.000478	0.00772	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Sibutramine—obesity	0.000462	0.00747	CcSEcCtD
Fluoxymesterone—NR3C1—endocrine gland—obesity	0.000446	0.0104	CbGeAlD
Fluoxymesterone—Paraesthesia—Orlistat—obesity	0.000429	0.00693	CcSEcCtD
Fluoxymesterone—Anxiety—Bupropion—obesity	0.000419	0.00677	CcSEcCtD
Fluoxymesterone—Paraesthesia—Sibutramine—obesity	0.000415	0.00671	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Bupropion—obesity	0.000403	0.00651	CcSEcCtD
Fluoxymesterone—NR3C1—liver—obesity	0.000402	0.00941	CbGeAlD
Fluoxymesterone—Stanozolol—AR—obesity	0.000396	0.0611	CrCbGaD
Fluoxymesterone—Haemoglobin—Topiramate—obesity	0.000363	0.00587	CcSEcCtD
Fluoxymesterone—Paraesthesia—Bupropion—obesity	0.000362	0.00585	CcSEcCtD
Fluoxymesterone—Haemorrhage—Topiramate—obesity	0.000361	0.00584	CcSEcCtD
Fluoxymesterone—Oxandrolone—AR—obesity	0.000357	0.055	CrCbGaD
Fluoxymesterone—Hypersensitivity—Orlistat—obesity	0.000352	0.00568	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Sibutramine—obesity	0.000341	0.0055	CcSEcCtD
Fluoxymesterone—Alopecia—Topiramate—obesity	0.000319	0.00516	CcSEcCtD
Fluoxymesterone—Headache—Orlistat—obesity	0.000299	0.00483	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Bupropion—obesity	0.000297	0.0048	CcSEcCtD
Fluoxymesterone—Headache—Sibutramine—obesity	0.00029	0.00468	CcSEcCtD
Fluoxymesterone—Nausea—Orlistat—obesity	0.000284	0.00458	CcSEcCtD
Fluoxymesterone—Nausea—Sibutramine—obesity	0.000275	0.00444	CcSEcCtD
Fluoxymesterone—Anxiety—Topiramate—obesity	0.000267	0.00431	CcSEcCtD
Fluoxymesterone—Danazol—CCL2—obesity	0.000257	0.0396	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—AKR1C3—obesity	0.000253	0.0389	CrCbGaD
Fluoxymesterone—Headache—Bupropion—obesity	0.000252	0.00408	CcSEcCtD
Fluoxymesterone—Nausea—Bupropion—obesity	0.000239	0.00387	CcSEcCtD
Fluoxymesterone—Paraesthesia—Topiramate—obesity	0.000231	0.00372	CcSEcCtD
Fluoxymesterone—Testolactone—CYP19A1—obesity	0.000223	0.0344	CrCbGaD
Fluoxymesterone—Testosterone Propionate—COMT—obesity	0.000194	0.0299	CrCbGaD
Fluoxymesterone—Hypersensitivity—Topiramate—obesity	0.000189	0.00306	CcSEcCtD
Fluoxymesterone—Desoximetasone—NR3C1—obesity	0.000167	0.0257	CrCbGaD
Fluoxymesterone—Loteprednol—NR3C1—obesity	0.000165	0.0254	CrCbGaD
Fluoxymesterone—Fludrocortisone—AR—obesity	0.000162	0.025	CrCbGaD
Fluoxymesterone—Headache—Topiramate—obesity	0.000161	0.0026	CcSEcCtD
Fluoxymesterone—Nausea—Topiramate—obesity	0.000152	0.00246	CcSEcCtD
Fluoxymesterone—Danazol—SHBG—obesity	0.000146	0.0225	CrCbGaD
Fluoxymesterone—Testosterone Propionate—AR—obesity	0.000145	0.0223	CrCbGaD
Fluoxymesterone—Hydrocortamate—NR3C1—obesity	0.000141	0.0218	CrCbGaD
Fluoxymesterone—Spironolactone—SHBG—obesity	0.00014	0.0216	CrCbGaD
Fluoxymesterone—Cortisone acetate—NR3C1—obesity	0.000139	0.0214	CrCbGaD
Fluoxymesterone—Megestrol acetate—NR3C1—obesity	0.000134	0.0206	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—SHBG—obesity	0.000131	0.0202	CrCbGaD
Fluoxymesterone—Amcinonide—NR3C1—obesity	0.000131	0.0202	CrCbGaD
Fluoxymesterone—Norethindrone—SHBG—obesity	0.00013	0.02	CrCbGaD
Fluoxymesterone—Danazol—AR—obesity	0.000128	0.0198	CrCbGaD
Fluoxymesterone—Mometasone—NR3C1—obesity	0.000125	0.0192	CrCbGaD
Fluoxymesterone—Methyltestosterone—SHBG—obesity	0.000124	0.019	CrCbGaD
Fluoxymesterone—Spironolactone—AR—obesity	0.000123	0.0189	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—AR—obesity	0.000115	0.0177	CrCbGaD
Fluoxymesterone—Clobetasol propionate—NR3C1—obesity	0.00011	0.017	CrCbGaD
Fluoxymesterone—Fludrocortisone—NR3C1—obesity	0.00011	0.017	CrCbGaD
Fluoxymesterone—Methyltestosterone—AR—obesity	0.000108	0.0167	CrCbGaD
Fluoxymesterone—Danazol—CYP19A1—obesity	0.000107	0.0165	CrCbGaD
Fluoxymesterone—Triamcinolone—BCHE—obesity	0.000107	0.0164	CrCbGaD
Fluoxymesterone—Fluorometholone—NR3C1—obesity	0.000106	0.0164	CrCbGaD
Fluoxymesterone—Danazol—ESR1—obesity	9.88e-05	0.0152	CrCbGaD
Fluoxymesterone—Hydrocortisone—SHBG—obesity	9.31e-05	0.0143	CrCbGaD
Fluoxymesterone—Methyltestosterone—CYP19A1—obesity	9.07e-05	0.014	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—obesity	8.87e-05	0.0137	CrCbGaD
Fluoxymesterone—Betamethasone—CYP19A1—obesity	8.75e-05	0.0135	CrCbGaD
Fluoxymesterone—Triamcinolone—NR3C1—obesity	8.66e-05	0.0133	CrCbGaD
Fluoxymesterone—Spironolactone—NR3C1—obesity	8.33e-05	0.0128	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—NR3C1—obesity	7.81e-05	0.012	CrCbGaD
Fluoxymesterone—Progesterone—SHBG—obesity	7.58e-05	0.0117	CrCbGaD
Fluoxymesterone—Progesterone—SLC22A1—obesity	7.48e-05	0.0115	CrCbGaD
Fluoxymesterone—Prednisolone—NR3C1—obesity	7.24e-05	0.0111	CrCbGaD
Fluoxymesterone—Testosterone—SHBG—obesity	7.17e-05	0.011	CrCbGaD
Fluoxymesterone—Betamethasone—NR3C1—obesity	7.09e-05	0.0109	CrCbGaD
Fluoxymesterone—Testosterone—SLC22A1—obesity	7.08e-05	0.0109	CrCbGaD
Fluoxymesterone—Progesterone—AR—obesity	6.65e-05	0.0102	CrCbGaD
Fluoxymesterone—Testosterone—AR—obesity	6.29e-05	0.00968	CrCbGaD
Fluoxymesterone—Hydrocortisone—NR3C1—obesity	5.54e-05	0.00853	CrCbGaD
Fluoxymesterone—Testosterone—CYP19A1—obesity	5.26e-05	0.0081	CrCbGaD
Fluoxymesterone—Progesterone—ESR1—obesity	5.12e-05	0.00789	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP19A1—obesity	5.09e-05	0.00784	CrCbGaD
Fluoxymesterone—Triamcinolone—PTGS2—obesity	4.91e-05	0.00757	CrCbGaD
Fluoxymesterone—Progesterone—NR3C1—obesity	4.51e-05	0.00695	CrCbGaD
Fluoxymesterone—Dexamethasone—NR3C1—obesity	4.12e-05	0.00635	CrCbGaD
Fluoxymesterone—Betamethasone—PTGS2—obesity	4.02e-05	0.0062	CrCbGaD
Fluoxymesterone—Norethindrone—ALB—obesity	3.91e-05	0.00603	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP2E1—obesity	3.8e-05	0.00585	CrCbGaD
Fluoxymesterone—Methyltestosterone—ALB—obesity	3.72e-05	0.00572	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—obesity	3.04e-05	0.000202	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PARP1—obesity	3.04e-05	0.000202	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—obesity	3.03e-05	0.000201	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR1I2—obesity	3.02e-05	0.000201	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—obesity	3.02e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CAV1—obesity	3.02e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOA1—obesity	3.01e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1B—obesity	3e-05	0.000199	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PARP1—obesity	2.99e-05	0.000199	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—obesity	2.91e-05	0.000193	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—obesity	2.9e-05	0.000192	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ESR2—obesity	2.88e-05	0.000191	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PRKCB—obesity	2.87e-05	0.000191	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—F2—obesity	2.87e-05	0.000191	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—obesity	2.86e-05	0.00019	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BAD—obesity	2.84e-05	0.000188	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR2—obesity	2.83e-05	0.000188	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARD—obesity	2.8e-05	0.000186	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	2.79e-05	0.000185	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK8—obesity	2.76e-05	0.000183	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARD—obesity	2.75e-05	0.000183	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CG—obesity	2.75e-05	0.000183	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS1—obesity	2.72e-05	0.00018	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1B—obesity	2.72e-05	0.00018	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—obesity	2.68e-05	0.000178	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR3C1—obesity	2.67e-05	0.000177	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—obesity	2.66e-05	0.000177	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—obesity	2.65e-05	0.000176	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NCOA1—obesity	2.65e-05	0.000176	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—obesity	2.63e-05	0.000175	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—POMC—obesity	2.62e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NCOA1—obesity	2.61e-05	0.000173	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—INS—obesity	2.6e-05	0.000173	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—obesity	2.6e-05	0.000172	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHRH—obesity	2.57e-05	0.000171	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NMB—obesity	2.57e-05	0.000171	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL2—obesity	2.56e-05	0.00017	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR0B2—obesity	2.55e-05	0.000169	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1I3—obesity	2.55e-05	0.000169	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—AR—obesity	2.54e-05	0.000169	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	2.52e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—obesity	2.52e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—obesity	2.52e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	2.52e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT2—obesity	2.52e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR0B2—obesity	2.51e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1I3—obesity	2.51e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—AR—obesity	2.5e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARA—obesity	2.5e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	2.48e-05	0.000165	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—obesity	2.45e-05	0.000163	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FFAR4—obesity	2.45e-05	0.000163	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—obesity	2.44e-05	0.000162	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CD—obesity	2.42e-05	0.00016	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SERPINE1—obesity	2.39e-05	0.000159	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—obesity	2.37e-05	0.000157	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	2.37e-05	0.000157	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MCHR1—obesity	2.35e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRS3—obesity	2.35e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHSR—obesity	2.35e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—obesity	2.34e-05	0.00361	CrCbGaD
Fluoxymesterone—ESR1—Gene Expression—NR1I2—obesity	2.33e-05	0.000155	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TYK2—obesity	2.33e-05	0.000154	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RHOA—obesity	2.31e-05	0.000153	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1I2—obesity	2.29e-05	0.000152	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3R1—obesity	2.28e-05	0.000152	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—obesity	2.28e-05	0.000152	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—obesity	2.28e-05	0.000151	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—obesity	2.27e-05	0.00015	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—obesity	2.21e-05	0.000147	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—obesity	2.21e-05	0.000146	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SH2B1—obesity	2.19e-05	0.000145	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRLHR—obesity	2.19e-05	0.000145	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GH1—obesity	2.19e-05	0.000145	CbGpPWpGaD
Fluoxymesterone—Testosterone—ALB—obesity	2.16e-05	0.00332	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	2.15e-05	0.000143	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—obesity	2.11e-05	0.00014	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTOR—obesity	2.11e-05	0.00014	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—obesity	2.1e-05	0.000139	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—obesity	2.07e-05	0.000137	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C1—obesity	2.06e-05	0.000136	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PYY—obesity	2.05e-05	0.000136	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APLN—obesity	2.05e-05	0.000136	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	2.01e-05	0.000134	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—obesity	1.99e-05	0.000132	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—obesity	1.99e-05	0.000132	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—obesity	1.97e-05	0.000131	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PNLIP—obesity	1.95e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARA—obesity	1.93e-05	0.000128	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SDC3—obesity	1.9e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PARP1—obesity	1.9e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARA—obesity	1.9e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—obesity	1.86e-05	0.000124	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—obesity	1.86e-05	0.000124	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NMU—obesity	1.86e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PMCH—obesity	1.86e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPY5R—obesity	1.86e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HCRT—obesity	1.86e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—obesity	1.84e-05	0.000122	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—obesity	1.83e-05	0.000122	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—obesity	1.83e-05	0.000121	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	1.82e-05	0.000121	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR2—obesity	1.8e-05	0.000119	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK8—obesity	1.78e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MC3R—obesity	1.78e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPY1R—obesity	1.78e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MC4R—obesity	1.78e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPY2R—obesity	1.78e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—obesity	1.76e-05	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPY—obesity	1.75e-05	0.000116	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—obesity	1.72e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC8—obesity	1.71e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCH—obesity	1.71e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GIP—obesity	1.71e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—obesity	1.7e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NCOA1—obesity	1.66e-05	0.00011	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—obesity	1.65e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.64e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEPR—obesity	1.63e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—obesity	1.63e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—obesity	1.62e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—obesity	1.59e-05	0.000106	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—obesity	1.59e-05	0.000106	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—obesity	1.57e-05	0.000104	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	1.55e-05	0.000103	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—obesity	1.53e-05	0.000101	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—obesity	1.52e-05	0.000101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—obesity	1.51e-05	0.0001	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—obesity	1.51e-05	0.0001	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PARP1—obesity	1.46e-05	9.71e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB3—obesity	1.46e-05	9.68e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SIRT1—obesity	1.45e-05	9.61e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PARP1—obesity	1.44e-05	9.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—obesity	1.43e-05	9.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GAL—obesity	1.42e-05	9.45e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—obesity	1.41e-05	9.37e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—C5AR1—obesity	1.41e-05	9.34e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ESR2—obesity	1.39e-05	9.19e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR2—obesity	1.36e-05	9.05e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKG1—obesity	1.29e-05	8.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCK—obesity	1.29e-05	8.55e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C1—obesity	1.28e-05	8.53e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—obesity	1.28e-05	8.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NCOA1—obesity	1.28e-05	8.47e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.27e-05	8.41e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NCOA1—obesity	1.26e-05	8.34e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PRKCD—obesity	1.26e-05	8.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RBP4—obesity	1.25e-05	8.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GLP1R—obesity	1.25e-05	8.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRH3—obesity	1.23e-05	8.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCKAR—obesity	1.23e-05	8.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AR—obesity	1.22e-05	8.12e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AR—obesity	1.21e-05	8e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARA—obesity	1.2e-05	7.99e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKAR2B—obesity	1.19e-05	7.89e-05	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—obesity	1.18e-05	7.82e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCF2—obesity	1.15e-05	7.62e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—obesity	1.14e-05	7.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPY—obesity	1.12e-05	7.42e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SIRT1—obesity	1.12e-05	7.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOC3—obesity	1.11e-05	7.38e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IAPP—obesity	1.11e-05	7.38e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SIRT1—obesity	1.1e-05	7.29e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—obesity	1.09e-05	7.24e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR1B—obesity	1.08e-05	7.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CRH—obesity	1.08e-05	7.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SDC1—obesity	1.07e-05	7.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1C3—obesity	1.05e-05	6.97e-05	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—obesity	1.05e-05	6.96e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPS—obesity	1.02e-05	6.79e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DRD1—obesity	1e-05	6.66e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2C—obesity	1e-05	6.66e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—obesity	9.95e-06	6.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C1—obesity	9.9e-06	6.57e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NTRK2—obesity	9.76e-06	6.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB1—obesity	9.72e-06	6.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PRKCD—obesity	9.67e-06	6.42e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PRKCD—obesity	9.53e-06	6.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PARP1—obesity	9.51e-06	6.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHRL—obesity	9.51e-06	6.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DRD4—obesity	9.43e-06	6.26e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARA—obesity	9.27e-06	6.15e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARA—obesity	9.13e-06	6.06e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—obesity	9.08e-06	6.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR1—obesity	9.01e-06	5.98e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—obesity	8.96e-06	5.95e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—obesity	8.94e-06	5.93e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TCF7L2—obesity	8.85e-06	5.87e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DRD2—obesity	8.79e-06	5.83e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GCG—obesity	8.7e-06	5.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTPN1—obesity	8.7e-06	5.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRL—obesity	8.3e-06	5.51e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—obesity	8.27e-06	5.49e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STK11—obesity	8.18e-06	5.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLG—obesity	8.09e-06	5.37e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FOXO3—obesity	7.89e-06	5.24e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB2—obesity	7.87e-06	5.22e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SOCS1—obesity	7.75e-06	5.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—obesity	7.67e-06	5.09e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SOCS3—obesity	7.66e-06	5.08e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—obesity	7.55e-06	5.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNB3—obesity	7.5e-06	4.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—obesity	7.36e-06	4.89e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNAS—obesity	7.3e-06	4.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOB—obesity	7.15e-06	4.74e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL5—obesity	6.98e-06	4.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—obesity	6.91e-06	4.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPL—obesity	6.83e-06	4.53e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—obesity	6.8e-06	4.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FOXO1—obesity	6.78e-06	4.5e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RPS6KB1—obesity	6.76e-06	4.49e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCD—obesity	6.29e-06	4.17e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2A—obesity	6.15e-06	4.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—C3—obesity	6.15e-06	4.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS2—obesity	5.85e-06	3.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGT—obesity	5.84e-06	3.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—obesity	5.72e-06	3.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—obesity	5.72e-06	3.8e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—obesity	5.67e-06	3.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CAV1—obesity	5.67e-06	3.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOA1—obesity	5.66e-06	3.75e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCB—obesity	5.4e-06	3.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—F2—obesity	5.4e-06	3.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BAD—obesity	5.33e-06	3.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—obesity	5.16e-06	3.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS1—obesity	5.1e-06	3.39e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—POMC—obesity	4.92e-06	3.26e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—obesity	4.89e-06	3.24e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—obesity	4.81e-06	3.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—obesity	4.73e-06	3.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT2—obesity	4.72e-06	3.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—obesity	4.54e-06	3.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—obesity	4.49e-06	2.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—obesity	4.37e-06	2.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TYK2—obesity	4.37e-06	2.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RHOA—obesity	4.33e-06	2.87e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—obesity	4.3e-06	2.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3R1—obesity	4.29e-06	2.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—obesity	4.29e-06	2.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—obesity	3.96e-06	2.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTOR—obesity	3.96e-06	2.63e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—obesity	3.93e-06	2.61e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—obesity	3.44e-06	2.28e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK8—obesity	3.34e-06	2.22e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—obesity	3.06e-06	2.03e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—obesity	3.03e-06	2.01e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—obesity	2.98e-06	1.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—obesity	2.84e-06	1.89e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—obesity	2.83e-06	1.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—obesity	2.41e-06	1.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—obesity	2.14e-06	1.42e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—obesity	1.97e-06	1.31e-05	CbGpPWpGaD
